Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of KDH-136 in Healthy Adults
jRCT2071230006Phase 1Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing KDH-136 single dose with Placebo single dose (2 arms). Primary endpoints: Safety and Pharmacokinetics. Started Oct 2023; status: completed.
02
Drugs
KDH-136
Beyond the preview
Go deeper on jRCT2071230006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230006.